Skip to main content

Advertisement

ADVERTISEMENT

Insights

Aging, Hypertension, and Dementia: Resolving the Mystery
Commentary
06/15/2020
Mark Munger, PharmD, poses the question: “Preventing heart disease by effective longitudinal treatment of hypertension is an attractive goal, but does it prevent, delay, or reduce dementia?”
Mark Munger, PharmD, poses the question: “Preventing heart disease by effective longitudinal treatment of hypertension is an attractive goal, but does it prevent, delay, or reduce dementia?”
Mark Munger, PharmD, poses the...
06/15/2020
Pharmacy Learning Network

Advertisement

Inducing Heart Failure Through Excess Antioxidants
Commentary
06/11/2020
Mark Munger, PharmD, discusses recent research that examines the impact of antioxidant supplementation on cardiovascular health.
Mark Munger, PharmD, discusses recent research that examines the impact of antioxidant supplementation on cardiovascular health.
Mark Munger, PharmD, discusses...
06/11/2020
Pharmacy Learning Network
CV Deaths, Hospitalizations Reduced for Patients Treated With Farxiga
Podcasts
05/29/2020
In this episode of PopHealth Perspectives, Kiersten Combs, vice president, US Cardiovascular and Metabolic Disease (US CVMD) and Naeem Khan, MD, vice president, medical, US CVMD, AstraZeneca, discuss the recent approval of Farxiga...
In this episode of PopHealth Perspectives, Kiersten Combs, vice president, US Cardiovascular and Metabolic Disease (US CVMD) and Naeem Khan, MD, vice president, medical, US CVMD, AstraZeneca, discuss the recent approval of Farxiga...
In this episode of PopHealth...
05/29/2020
First Report Managed Care
Is Breakfast Important to Cardiovascular Health? Further Support for an Important Daily Meal
Commentary
05/27/2020
Mark Munger, PharmD, discusses why clinicians should pay closer attention to dietary intake, especially meal consumption during the day as part of their overall cardiovascular assessment.
Mark Munger, PharmD, discusses why clinicians should pay closer attention to dietary intake, especially meal consumption during the day as part of their overall cardiovascular assessment.
Mark Munger, PharmD, discusses...
05/27/2020
Pharmacy Learning Network

Advertisement

Is the CHA2-DS2-VASc Score Consistent in Predicting Clinical Outcomes in AF and Flutter?
Commentary
05/11/2020
Mark Munger, PharmD, discusses the question: does the CHA2-DS2-VASc Score system equivalently predict outcomes in atrial flutter and fibrillation?
Mark Munger, PharmD, discusses the question: does the CHA2-DS2-VASc Score system equivalently predict outcomes in atrial flutter and fibrillation?
Mark Munger, PharmD, discusses...
05/11/2020
Pharmacy Learning Network
Importance of Early Palliative Care Interventions for Family Caregivers
Videos
05/07/2020
J. Nicholas Dionne-Odom, PhD, APRN, Center for Palliative and Supportive Care, Division of Gerontology, Geriatrics, and Palliative Care, University of Alabama at Birmingham, discusses why a telehealth intervention for family caregivers of...
J. Nicholas Dionne-Odom, PhD, APRN, Center for Palliative and Supportive Care, Division of Gerontology, Geriatrics, and Palliative Care, University of Alabama at Birmingham, discusses why a telehealth intervention for family caregivers of...
J. Nicholas Dionne-Odom, PhD,...
05/07/2020
Annals of Long-Term Care
Reducing Major Bleeding, CVD-Associated Deaths With Edoxaban
Podcasts
05/05/2020
Robert Giugliano, MD, cardiovascular medicine specialist at Brigham and Women's Hospital, discusses the results of the ENGAGE AF-TIMI 48 trial explaining the benefits of treating patients with edoxaban, and why he encourages health care...
Robert Giugliano, MD, cardiovascular medicine specialist at Brigham and Women's Hospital, discusses the results of the ENGAGE AF-TIMI 48 trial explaining the benefits of treating patients with edoxaban, and why he encourages health care...
Robert Giugliano, MD,...
05/05/2020
First Report Managed Care

Advertisement

Is Warfarin Beneficial in Reducing Ischemic Stroke Incidence in Patients With AF, End-Stage Renal Disease?
Videos
05/04/2020
Mandeep S Randhawa, MD, division of cardiology, Michigan State University, discusses his recent study and explains why warfarin provides no benefit for ischemic stroke incidence or mortality, as well as increase the risk of hemorrhagic...
Mandeep S Randhawa, MD, division of cardiology, Michigan State University, discusses his recent study and explains why warfarin provides no benefit for ischemic stroke incidence or mortality, as well as increase the risk of hemorrhagic...
Mandeep S Randhawa, MD, division...
05/04/2020
Pharmacy Learning Network
Policy Solution Considerations Needed to Lower Spending Among Dually Enrolled Veterans
Videos
04/14/2020
Elias Dayoub, MD, MPP, internal medicine physician and research fellow, discusses his recent study that observed veterans enrolled in both the VA and Medicare Advantage plans who underwent coronary revascularization, and explains why the...
Elias Dayoub, MD, MPP, internal medicine physician and research fellow, discusses his recent study that observed veterans enrolled in both the VA and Medicare Advantage plans who underwent coronary revascularization, and explains why the...
Elias Dayoub, MD, MPP, internal...
04/14/2020
Veterans Health Today
Data Supports Statin Use Following Myocardial Infarction in OAs
Interview
04/14/2020
Geert Lefeber, MD, geriatrician and clinical pharmacologist, explains why older adults should initiate statins for a minimum of two years after the first myocardial infarction to achieve benefit, regardless of a patient’s age.
Geert Lefeber, MD, geriatrician and clinical pharmacologist, explains why older adults should initiate statins for a minimum of two years after the first myocardial infarction to achieve benefit, regardless of a patient’s age.
Geert Lefeber, MD, geriatrician...
04/14/2020
Annals of Long-Term Care

Advertisement

Advertisement